To include your compound in the COVID-19 Resource Center, submit it here.

VITX suspends Inactine enrollment

V.I. Technologies (VITX) suspended enrollment in a Phase III

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE